Share your videos with the world

Bad dietary habits and modern sedentary lifestyles have converged to create a worldwide epidemic that is constantly increasing: obesity (BMI > 30). One billion adults around the world and twenty-two million children under the age of 5 are overweight. Faced with this problem, LPG wanted to study the effect of LPG® mechano stimulation on fat cells to obtain proven results of the impact of Cellu M6® on localised areas of fat. To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/lpg/50526/

Dendreon Corporation (Nasdaq: DNDN) announced significant milestones that support broad availability for on-label use of PROVENGE® (sipuleucel-T), the first autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer (mCRPC). To view Multimedia News Release, go to http://www.multivu.com/mnr/50924-dendreon-provenge-cellular-immunotherapy

Raytheon Company (NYSE: RTN) unveiled its second generation Exoskeleton (XOS 2) at its research facility in Salt Lake City, Utah, during a demonstration with Paramount Home Entertainment. The new robotic suit is lighter, faster and stronger than its predecessor, yet it uses 50 percent less power. Its enhanced design also means that it is more resistant to the environment. To view Multimedia NewsRelease, go to http://multivu.prnewswire.com/mnr/raytheon/46273/